2018 American Transplant Congress
MELD-Na Score Based Liver Allocation: Hyponatremia is No Longer a Risk Factor for Waitlist Mortality
Background: Hyponatremia is associated with an increased risk of liver transplant (LT) waitlist mortality. The aim of this study was to compare waitlist outcomes between…2018 American Transplant Congress
Contemporary Practice Patterns & Outcomes after Transjugular Intrahepatic Portosystemic Shunt (TIPS) Placement: A Multicenter US Experience of 1,146 Patients
Background: TIPS is effective for treating complications of portal hypertension. Historic, single center data suggest poor outcomes for MELD scores >15. We assessed contemporary outcomes…2018 American Transplant Congress
Advanced Liver Care and Salvage Transplantation Improves Outcomes for Patients with Cirrhosis Requiring Abdominal General Surgical Procedures
Introduction: Historically, abdominal general surgical procedures on cirrhotic patients carry up to an 80% mortality rate. We hypothesized outcomes of cirrhotic patients requiring abdominal surgical…2018 American Transplant Congress
Risk Factors of De Novo Malignancies after Liver Transplantation
De novo malignancies after liver transplantation (LT) are one of the leading causes of late mortality, with a reported risk of malignancies twice as high…2018 American Transplant Congress
Transplant Trends in Young Adults: Silent Alcohol Epidemic
1Gastroenterology, USF, Tampa; 2Transplant Hepatology, Tampa General Medical Group, Tampa.
With the introduction of effective antiviral therapy for HCV, there is a paradigm shift in liver disease with a decline in HCV but a parallel…2018 American Transplant Congress
Sustained Improvement in Patient Reported Outcomes 10 Years after Liver Transplantation by Protocol Longitudinal Assessment of Health Related Quality of Life
Purpose: Data on patient (pt) reported outcomes, especially beyond the first year after liver transplantation (LT) are scarce. We examined changes in health related quality…2018 American Transplant Congress
Kidney Transplantation Alone in End-Stage Renal Disease Patients with Hepatitis B Liver Cirrhosis
BackgroundKidney transplantation (KT) alone in end-stage renal disease (ESRD) patients with hepatitis B virus-induced liver cirrhosis (LC) remains controversial. This study compared outcomes of KT…2018 American Transplant Congress
Protein S Deficiency as an Independent Risk Factor for Portal Vein Thrombosis in Cirrhotic Patients Awaiting Liver Transplantation
Background: Portal vein thrombosis (PVT) in cirrhotic patients not only induces lethal complications on waiting, but also complicates surgical procedures and increases risk during transplantation.…2018 American Transplant Congress
Poverty, End Stage Liver Disease, and Transplantation in Georgia
1Surgery, Emory University, Atlanta, GA; 2Medicine, University of Pennsylvania, Philadelphia, GA.
Background: Though discussions of equity in liver transplantation remain focused primarily on relative availability of allografts as a measure of access, differences in disease burden…2018 American Transplant Congress
Intervention for Splenorenal Shunt May Decrease the Incidence of Post-Liver Transplant Acute Kidney Injury
Dept. of Surgery, University of Virginia Health System, Charlottesville, VA.
Background: Splenorenal shunt (SRS) is a type of portosystemic shunt that develops frequently in the setting of chronic portal hypertension and cirrhosis. It remains controversial…
- « Previous Page
- 1
- …
- 8
- 9
- 10
- 11
- 12
- …
- 14
- Next Page »